Immunogenicity and safety of a nine-valent human papillomavirus vaccine in Vietnamese males and females (9 to 26 years of age): an open-label, phase 3 trial

• Main Authors: Vu Dinh Thiem (Author), Nguyen Dang Quang (Author), Nguyen Hai Tuan (Author), Kyeongmi Cheon (Author), Nancy Gallagher (Author), Alain Luxembourg (Author), Thomas Group (Author), Cyrus Badshah (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This open-label, single-center, Phase 3 study (NCT03546842) assessed the immunogenicity and safety of the nine-valent human papillomavirus (9vHPV; HPV6/11/16/18/31/33/45/52/58) vaccine in Vietnamese males and females, with the aim to support 9vHPV vaccine licensure in Vietnam. Participants aged 9-26...